Navigation Links
Chitosan conduits combined with NGF microspheres repair facial nerve defects
Date:12/27/2013

The chitosan molecule can promote nerve cell adherence and growth along the surface of the material. It can enhance the adherence and influx of Schwann cells, thus encouraging the growth of axons. However, physical nerve guidance by a nerve conduit may not be sufficient to foster optimal recovery. Dr. Huawei Liu and colleagues from Institute of Stomatology, Chinese PLA General Hospital in China prepared microspheres containing nerve growth factor for sustained release by a compound method, and implanted them into chitosan conduits to repair 10-mm defects on the right buccal branches of the facial nerve in rabbits. Researchers found that the sustained in vitro release of active nerve growth factor lasted for at least 90 days. The muscular atrophy induced by facial nerve defects was attenuated, and the nerve conduction velocity and amplitude were significantly increased. Moreover, microspheres for sustained release of nerve growth factor in combination with chitosan conduits improved axon and myelin sheath regeneration of injured facial nerve. These findings, published in the Neural Regeneration Research (Vol. 8, No. 33, 2013), indicate that the combination of nerve growth factor-releasing microspheres and chitosan conduits exhibits superior effects in repairing facial nerve injury compared with nerve growth factor alone.


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related biology news :

1. Neural stem cell transplants for spinal cord injury maximized by combined, complimentary therapies
2. Combined pesticide exposure affects bumblebee colony success
3. Synthetic and biological nanoparticles combined to produce new metamaterials
4. Combined therapy could repair and prevent damage in Duchenne muscular dystrophy
5. Ingredient in turmeric spice when combined with anti-nausea drug kills cancer cells
6. Stem cells can repair a damaged cornea
7. Epigenetic signatures direct the repair potential of reprogrammed cells
8. New heart repair strategies discussed at UH lecture May 15
9. Heart Damage Repaired By Reprogramming Resident Fibroblasts into Functioning Heart Cells
10. Scientists tie DNA repair to key cell signaling network
11. Detector of DNA damage: Structure of a repair factor revealed
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chitosan conduits combined with NGF microspheres repair facial nerve defects
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology: